Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)
Syndax Pharmaceuticals
Syndax Pharmaceuticals
UNC Lineberger Comprehensive Cancer Center
Bayer
National Institutes of Health Clinical Center (CC)